An open labelled randomized control trial to assess combined effect of shankara vati and arjuna ksheerapaka in vata kaphaja hridroga vis-a-vis ischemic heart disease

An open labelled randomized control trial to assess combined effect of shankara vati and arjuna ksheerapaka in vata kaphaja hridroga vis-a-vis ischemic heart disease - Nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/06/112612

Enrollment

Registered

2026-06-12

Start date

Unknown

Completion date

Unknown

Last updated

2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I20-I25- Ischemic heart diseases

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion Criteria 1. Subjects with stable Ischemic Heart Disease and undergoing ongoing modern treatment. 2. Subjects with signs and symptoms of Ischemic Heart Disease such as chest pain, exertional dyspnea, palpitations, and pedal edema. 3. Subjects with signs and symptoms of Vata-Kaphaja Hridroga such as Hritshula, Arohanayasa, Hrudrava, Bhrama, and Padashopha. 4. Subjects between the age group of thirty to seventy years. 5. Subjects having an ejection fraction greater than thirty-five percent. 6. Subjects who are willing to provide informed consent.

Exclusion criteria

Exclusion criteria: CCF, Multiorgan failure, Acute M.I Pregnant and lactating mother.

Design outcomes

Primary

Measure	Time frame
To assess the efficacy of Shankara Vati and Arjuna Ksheerapaka in vata-kaphaja hridroga wsr to Ischemic heart diseaseTimepoint: Day 1, Day 15, Day 38, Day 53	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDr Fareeda Begum Shaikh

Taranath Government Ayurveda medical college and hospital, Bellary, 583101

drfareedabegumshaikh@gmail.com9886478611

Outcome results